RKLB (Trans): Backlog Surges to $3.6bn, Neutron Price Hike

Compiled by Dolphin Research:$Rocket Lab(RKLB.US) FY26 Q3 earnings call Trans

I. Core takeaways

1) Q4 guidance. Details follow.

a) Revenue of $270–290 mn, mid-point +4.5% QoQ and +55.9% YoY. Launch to post strong growth, while Space Systems sees solar and satellite platforms normalize from highs with other lines up.

b) GAAP GPM at 34%–36%, non-GAAP at 39%–41%. QoQ improvement driven by mix optimization between Launch and Space Systems and within Space Systems.

c) GAAP Opex $162–168 mn, non-GAAP $136–142 mn. Incremental spend tied to Neutron pre-first-flight R&D and testing.

d) Net interest income ~$45 mn; Adj. EBITDA loss of $14–20 mn. Basic weighted shares ~681 mn, and FCF remains a sizable net outflow.

2) Q3 margin and opex drivers. Summary below.

a) GPM declined QoQ mainly due to the first full-quarter consolidation of Mynaric and the absence of Q2 tariff refunds. The drop was less than expected on better solar and Geost optical performance and improved absorption as Electron cadence increased.

b) Recorded a forward-loss reserve for Neutron flight 2, reflecting profitability uncertainty for early-build units on that mission.

c) GAAP Opex exceeded guide largely on Iridium transaction costs, including $9.4 mn Term Loan B change-of-control fees. R&D step-up centered on Neutron first-flight engines and composite structures, while non-GAAP S&M fell ~$2.8 mn QoQ on M&A synergies.

3) Cash flow and capital structure. Key points follow.

a) Operating cash flow turned positive at $7.2 mn on higher satellite milestone receipts, though such payments are lumpy.

b) ATM was completed mid-Sep., issuing 36.8 mn shares to raise approx. $2.4 bn, ending cash and marketable securities at ~$4.7 bn. Together with the revised Iridium term loan, funds fully cover the purchase price, the $3.6 bn bridge commitment was terminated, and no refinancing is required.

c) Capex and Neutron spend to remain elevated through first flight. Spend will gradually shift from R&D to subsequent production inventory.

4) Backlog: ~$3.6 bn at quarter-end, +52% QoQ, with Launch at 52% and Space Systems at 48%, covering 117 launches and 55+ spacecraft. About 32.9% expected to convert to revenue over the next 12 months, with quick-turn biz. adding upside.

II. Call details

2.1 Management remarks

1) Full-year review. Context below.

a) Revenue grew from $35.2 mn in 2020 to nearly $1 bn guided for 2026. GAAP GPM projected around 35% in 2026, non-GAAP above 40%, up over 6,900 bps vs. 2020.

b) M&A this year filled gaps in laser comms, robotics, payloads, and machining capabilities.

2) Space Systems. Performance was strong.

a) YTD new bookings of $688 mn (+319% YoY); Q3 alone booked $417 mn (+512% YoY). Backlog stands at $1.7 bn.

b) Twelve in-house satellites reached orbit over the past 12 months, with 55+ in development/production across SDA PWSA, NASA, Space Force, and commercial constellations. Component lines nearly all exceeded annual goals.

3) Launch. Demand and execution improved.

a) Q3 launch awards exceeded $1 bn, including the two largest batches in company history: 18 HASTE for Space Systems Command and 20 Electron for a long-time commercial customer.

b) Electron is rolling off the line about every 8 business days, with the 100th launch expected within a week, potentially the fastest commercial rocket to 100 flights. Success rate stands at 96% over 99 launches.

c) Neutron booked eight launches in the quarter totaling about $515 mn, with multi-launch deals at a new $70 mn baseline price. The first 16 flights are sold out, the next slots extend into the 2030s, and in-house capacity is reserved; no first-flight discount as the company targets a tight market at full or higher pricing.

4) Neutron development. Latest status as follows.

a) First flight moves to 2027 due to a gap found in the first-stage tank forward dome. AFP has laid and cured the new dome with good quality, the mid-section is stacked, next up are forward and aft sections and hydro-proof before shipping to LC-3 for cryo qual.

b) The second stage has arrived at LC-3 for cryo validation and a wet dress without engines. The thrust module is on-pad, testing clamp-release, quick-disconnects, and other interfaces.

c) Archimedes vacuum variant completed cold-flow testing, and the first-flight engine set is in build. Management is evaluating a post-first-flight ramp in Archimedes mass production.

5) Iridium acquisition: funding is fully secured, Iridium shareholders approved by a wide margin, regulatory approvals in process with an aim to close ASAP. The prior 'Space Applications' framing is renamed 'Space Services', referring to recurring revenue from owned constellations.

2.2 Q&A

Q: With the Neutron first flight pushed, how do you see the path to flight 10?

A: No change to the 1-3-5 ramp for now, while working aggressively behind the scenes to accelerate. The delay period is focused on boosting cadence so we reach flight 10 faster.

Q: With Neutron pricing at $70 mn, is there room to raise Electron and HASTE pricing?

A: Neutron is clearing at $70 mn, and Electron and HASTE will also see price hikes. Neutron pricing will rise off this new baseline; Electron demand is inflecting again and higher prices are already showing in backlog. HASTE’s mix in backlog is rising with a higher ASP, and a broad-based price lift will flow through the model over time.

Q: Latest view on orbital data centers?

A: Still cautious, but constructive on defense-grade orbital data centers, and we have not walked away. We launched a new silicon solar cell for orbital data centers and already have a Neutron order from one such customer; if conviction builds, we have the capability to execute.

Q: Is the biggest bottleneck technical or economic?

A: Economics are central; major technical breakthroughs are needed to make the math work. Small-scale in-orbit data centers are feasible, and secure comms/defense use cases will happen; lifting an entire data center to orbit still faces many hurdles.

Q: Multi-year Electron outlook and growth once Neutron co-exists?

A: Next year is a big year for Electron, with the constraint on market, not capacity. Electron is non-reusable, so step-change cadence comes from reusable Neutron; next year’s manifest is packed and rideshare exits elsewhere make Electron the logical next choice. Doubling or tripling capacity is a matter of replicating lines with no tech barrier, and multiple global pads are sufficient.

Q: Any notable bottlenecks in the space supply chain?

A: We are highly vertically integrated, with concerns mainly in raw materials. Critical minerals and other inputs remain challenges across industries rather than specific parts.

Q: Why are customers booking Neutron before first flight?

A: Only SpaceX and Rocket Lab have developed, listed, and scaled commercially. Customers tour our factories and pads, and we maintain high transparency on R&D progress; given poor industry execution overall, we have deliberately built the opposite reputation.

Q: Does the ~20% growth for HASTE and commercial Electron in 2027 still hold?

A: 20% is not at risk, and next year could grow faster than 2025→2026. Demand and pricing are set; execution is key as both rockets and customer payloads must be ready, and past cadence volatility often came from late-stage payload test issues. Backlog is ample, allowing task swaps to maintain rhythm, and capacity can support faster growth next year.

Q: Are HASTE and MACH-TB exposed to budget reconciliation risk?

A: We see no reconciliation risk; both enjoy bipartisan support and long histories, implying low risk.

Q: AST SpaceMobile plans to build its own rockets—how do you view new entrants?

A: Lift capacity is extremely tight, and even with Neutron online demand won’t be fully met, so more entrants are welcome. Half of Neutron capacity will be external and half internal; large space companies will need in-house launch over time, which has always been our view.

Q: Cash generation excluding Iridium, and cash flow profile post consolidation?

A: True FCF inflection awaits Neutron mass production. Electron pricing and Neutron prepayments help, but Space Systems scale is not yet enough to offset Neutron investment; Iridium brings strong cash flow, materially changing the picture post close.

Q: What extra work was done during the Neutron delay, and implications for the 1-3-5 cadence and reuse?

A: All efforts target faster launch cadence, with cadence pressure being overwhelming. Engine build/acceptance and composite structure build/acceptance are being accelerated in parallel, and avionics/fluids expansions continued despite tank delays; we have good cadence options and will disclose once finalized.

Q: Neutron R&D spend and 2027 Adj. EBITDA/profitability outlook?

A: Adj. EBITDA turns positive within six months of the first successful flight, with FCF positive later. Space Systems R&D intensity is modest, LT revenue growth targeted at ~20%, with Launch growing faster; cash flow depends on fleet investment as cadence measures may be capital intensive.

Reusable rockets require peak build early, with margins expanding materially once reuse scales. No large R&D outside Neutron, and Iridium could add R&D to accelerate growth post close.

Q: Neutron materials cost and LT GPM?

A: LT non-GAAP GPM 50%+, with price increases speeding attainment. Launch margins hinge more on fixed-cost absorption than the BOM, with annual BOM savings of ~6%–10% far less impactful than cadence moving from three to five to ten per year; facilities, headcount, pads, and recovery vessels drive cost, and Neutron pricing has not peaked.

Q: Is Iridium’s L-band spectrum sufficient for long-term constellation plans?

A: L-band is sufficient for now, with no near-term spectrum M&A plans. L-band penetrates adverse weather well and fits safety/defense-critical scenarios with strong growth potential; we are now in the comms business and will keep watching spectrum.

Q: Neutron demand pipeline—can Q4 or Q1 repeat Q3’s bookings?

A: No bookings outlook given; we are intentionally signing fewer deals at higher prices. We could have signed more Neutron in Q3, but some customers bid slightly lower; we chose high ASP and low volume, expect further price upside, and are not rushing to sell out capacity at today’s price while reserving half for internal use.

Q: Terms and use of the $150 mn Office of Strategic Capital (OSC) loan commitment?

A: Rate is roughly SOFR +100 bps, primarily to accelerate Neutron scaling. It is non-dilutive and underscores the Gov.’s focus on alleviating launch capacity shortages with real capital.

Q: Impact of continuing resolutions (CR) on 2027?

A: Hard to predict, but many of our programs are already appropriated, implying low risk. Greater clarity on budget direction would help.

Q: What drove the +47% QoQ increase in next-12-month backlog?

A: Mainly Electron and HASTE, both entering a new growth leg. The market is recognizing that demand will shift to Electron as SpaceX’s Transporter and Bandwagon rideshares phase out, and the impact may just be starting.

Space Systems is approaching 80% of revenue; platform megadeals are getting larger with longer, lumpier sales cycles. No large platform award booked this quarter, with more to come.

Q: Next focus areas for Space Systems?

A: Opportunities are broad-based, and the business has reached a mature, steady rhythm. Off-the-shelf components, reusable designs, and reliable delivery are driving rising repeat customers; overseas space spend is not yet in the model, and current platform backlog skews to U.S. SDA Tranche 2/3 and AMTI, benefiting full-stack players given limited industrial bases abroad.

Q: When is the first in-house Neutron launch, and will it support Iridium replenishment?

A: In-house launches are not imminent, with near-term capacity tilted heavily to customers. Our own platforms enable low-cost tech validation; Iridium will eventually need replacement, where Neutron is key. The 50/50 split is a long-term view, and multiple proprietary services beyond Iridium are planned.

Q: Progress on the Alaska site—still on track for a 2027 maiden flight, and what is annual capacity?

A: Two side-by-side pads remain on track for 2027 launches. The minimum interval between two launches is 16 hours 42 minutes, providing ample throughput.

Q: Post Iridium close, what initiatives could accelerate growth within two years?

A: PNT and direct-to-device (D2D) are priorities. Iridium has been investing for years, and under Rocket Lab we can push more aggressively to land these sooner.

Q: If Electron grows 20%+ next year, how do you split standard Electron vs. HASTE?

A: No 2027 guide; HASTE to be ~25% of next year’s small dedicated launches. HASTE generally runs about 15 missions, but is highly dependent on customer program timing with significant quarterly volatility.

Q: For Neutron’s 2027 first flight, which quarter or month is the internal target?

A: No specific date; first we must complete all first-stage tank testing. We are shifting to weekly or even daily tank updates and prefer not to repeat timing miscalls.

Q: As the industry moves to larger rockets, do you need something bigger than Neutron?

A: Neutron covers all current plans, though we avoid absolutes. Ex-Starlink, Falcon 9’s commercial payload averages ~5t; Neutron is sized at ~13t to support crewed flight. For constellation deployment, the key metric is cost to orbit per satellite; only pure tonnage plays like data centers argue for very large rockets.

Q: Under a high-price strategy, how far out are customers willing to book Neutron?

A: No bid has warranted taking a large block of capacity, and we are testing price elasticity. The market has moved a lot in six months and may keep moving; we will keep headroom to push ASP higher.

Q: With half of Neutron for internal use long term, will satellite manufacturing shift to scaled mass production?

A: Yes, satellite manufacturing will scale materially, with components already in mass production. We are the world’s largest space-grade solar cell maker; the Flatellite platform has U.S. Gov. awards and is the No. 2 supplier on Starshield.

Q: With Neutron first-flight timing uncertain, can customers cancel or switch per contract?

A: Contracts include real deposits and cancellation fees, not option-like orders. Terms are similar to standard Electron launch services; early customers understand it is a new rocket, we keep them updated, and they still view us as the best choice.

Risk disclosure and statements:Dolphin Research disclaimer and general disclosures